News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
19,555 Results
Type
Article (2056)
Company Profile (13)
Press Release (17486)
Section
Business (5913)
Career Advice (62)
Deals (787)
Drug Development (3267)
Employer Resources (3)
FDA (590)
Job Trends (759)
News (10253)
Policy (730)
Tag
Academia (279)
Alliances (1723)
ALS (8)
Alzheimer's disease (280)
Approvals (585)
Artificial intelligence (12)
Bankruptcy (5)
Best Places to Work (732)
Biotechnology (11)
Cancer (31)
Career advice (49)
Cell therapy (9)
Clinical research (2520)
Collaboration (41)
Compensation (7)
COVID-19 (44)
C-suite (10)
Data (74)
Depression (23)
Diagnostics (68)
Earnings (1322)
Events (2745)
Executive appointments (33)
FDA (616)
Funding (27)
Gene therapy (8)
GLP-1 (24)
Government (75)
Healthcare (570)
Immunology and inflammation (6)
Infectious disease (44)
Inflammatory bowel disease (9)
Interviews (12)
IPO (298)
Job creations (92)
Job search strategy (45)
Layoffs (23)
Legal (89)
Medical device (253)
Medtech (254)
Mergers & acquisitions (515)
Metabolic disorders (6)
Multiple sclerosis (13)
Neurodegenerative disease (16)
Neuropsychiatric disorders (8)
Neuroscience (408)
NextGen: Class of 2025 (231)
Non-profit (217)
Northern California (69)
Opinion (8)
Pain (5)
Parkinson's disease (29)
People (2512)
Phase I (571)
Phase II (938)
Phase III (1154)
Pipeline (24)
Postmarket research (133)
Preclinical (374)
Psychedelics (8)
Radiopharmaceuticals (6)
Rare diseases (12)
Real estate (150)
Regulatory (622)
Research institute (235)
Resumes & cover letters (9)
Schizophrenia (33)
Series A (8)
Southern California (122)
Startups (144)
United States (769)
Vaccines (7)
Venture capitalists (5)
Date
Today (3)
Last 7 days (24)
Last 30 days (121)
Last 365 days (1580)
2025 (117)
2024 (1573)
2023 (1665)
2022 (1853)
2021 (2030)
2020 (1585)
2019 (1357)
2018 (1037)
2017 (1050)
2016 (1058)
2015 (1216)
2014 (870)
2013 (642)
2012 (614)
2011 (532)
2010 (457)
Location
Africa (16)
Asia (1347)
Australia (179)
California (213)
Canada (90)
China (21)
Colorado (6)
Connecticut (17)
Europe (3209)
Florida (44)
Illinois (53)
Indiana (15)
Japan (7)
Maryland (26)
Massachusetts (176)
Minnesota (8)
New Jersey (42)
New York (77)
North Carolina (12)
Northern California (69)
Ohio (6)
Pennsylvania (49)
South America (18)
Southern California (122)
Texas (12)
Utah (6)
Washington State (10)
19,555 Results for "amygdala neurosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioCapital
ABMRF Invests in Amygdala Neurosciences to Develop ANS-858 for Alcohol Use Disorder
Amygdala Neurosciences announced that the Company has closed a new round of equity financing led by ABMRF, the Alcohol Beverage Medicines Research Foundation to fund the Company’s IND-stage activities for ANS-858.
May 14, 2024
·
4 min read
Biotech Bay
Amygdala Neurosciences Awarded $2.0 million NIH Grant to Conduct IND Enabling Studies
Amygdala Neurosciences has been awarded a $2.0 million NIH grant to support the project titled “Investigational New Drug -enabling and Early-Stage Development of Selective, Reversible, Orally Bioavailable ALDH2 inhibitor ANS-00858 to Treat Alcohol Use Disorder.”
August 1, 2023
·
3 min read
Press Releases
Vistagen to Present at the 2024 Neuroscience Education Institute Congress
November 5, 2024
·
6 min read
Press Releases
ProMIS Neurosciences Issues Letter to Shareholders
January 14, 2025
·
9 min read
Press Releases
Mytos Announces Manufacturing Collaboration with Aspen Neuroscience in Parkinson’s Disease
January 8, 2025
·
3 min read
Press Releases
Firefly Neuroscience Closes on Financing of up to $12.4 Million
December 31, 2024
·
5 min read
Press Releases
Reunion Neuroscience Announces Program Updates and Highlights Anticipated 2025 Milestones
January 6, 2025
·
5 min read
Press Releases
Jupiter Neurosciences Announces Strategic Focus on NLRP3 Pathway in Future JOTROL™ Trials
January 14, 2025
·
6 min read
Press Releases
Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.
January 13, 2025
·
20 min read
Press Releases
Firefly Neuroscience Announces Publications Demonstrating the Utility of Advanced EEG Analytics in Drug Development and Neuropsychiatric Care
January 24, 2025
·
6 min read
1 of 1,956
Next